Pope Francis to attend Cop28 in Dubai despite lung inflammation

Pope Francis on Sunday revealed that he has a lung inflammation but will go later this week to Dubai to address the climate change conference.

Pope Francis skipped his weekly Sunday appearance at a window overlooking St Peter’s Square, a day after the Vatican said he was suffering from a mild flu.

Instead, the pope gave the traditional noon blessing in an appearance televised live from the chapel in the Vatican hotel where he lives.

“Brothers and sisters, happy Sunday. Today I cannot appear at the window because I have this problem of inflammation of the lungs,” said the pontiff.

Quashing of Harvey Weinstein’s rape conviction draws prompt parallels with Donald Trump trial

---

Macron returns to the Sorbonne to warn of Europe’s mortality

---

US student protests: ‘You see a lot of hate on campus’

---

Togo president seeks to extend family rule into seventh decade

---

The pontiff, whose 87th birthday is next month, added that a priest sitting beside him would read out his day’s reflections for him.

In those comments, Pope Francis said he was going to the United Arab Emirates for the Cop28 gathering on climate change and that he would deliver his speech, as scheduled, on Saturday to the participants.

He described the climate change problem as serious, especially for young people.

On his right hand he had a bandage and what appeared to be a cannula. The Vatican did not respond immediately to a query about whether he was receiving intravenous treatment.

Not immediately explained was the discrepancy between the pope saying he has lung inflammation and the Vatican saying a day earlier that he had a CAT scan at a Rome hospital for pulmonary complications and that the exam was negative.

Pope Francis thanked all those who would be following his three-day trip to Dubai with prayers.

Pope Francis earlier this year was hospitalised for three days for what he later said was pneumonia and what the Vatican described as a case of bronchitis necessitating treatment with intravenous antibiotics. – AP